Sponsored Content

NutraIngredients | EVANIUM raises €2.2 million to deliver dual encapsulation technology

23 Apr 2026

FoodLabs and Feast Ventures back OPTISOLV® Technology to solve the bioavailability crisis behind costly, ineffective supplements – The seed funding will accelerate EVANIUM’s ingredient platform, expand its portfolio following the successful OPTISOLV® Curcumin launch with Hevert-Arzneimittel, and support clinical validation and market expansion.

Addressing inefficiencies in nutraceuticals

Regensburg, April 14 – Despite premium pricing, many nutraceutical supplements deliver only a fraction of their promised benefits, as large parts of the active ingredients are poorly absorbed. In some cases, less than 1% of the ingredient can be effectively used by the human body. EVANIUM, a life-science startup from Regensburg, Germany, is addressing this fundamental inefficiency with a new generation of bioavailability-enhanced ingredients.

OPTISOLV®: A breakthrough in bioavailability

Built around a dual‑coating system, OPTISOLV® combines an inner cyclodextrin-based core with an outer phospholipid shell, stabilising natural actives in a crystal‑free, highly dispersible state. This structure prevents re‑agglomeration, improves permeability, and enables dramatically higher solubility and absorption, using only natural materials. For challenging actives such as Curcumin, the improvement is more than 1,000x in solubility and more than 170x better release during digestion, compared to the native form, outperforming conventional phospholipid-based approaches in a side-by-side comparison.

From validation to market proof

EVANIUM has already demonstrated that OPTISOLV® works beyond the lab. In 2025, the company successfully launched OPTISOLV® Curcumin together with Hevert-Arzneimittel, one of the leading German manufacturers of herbal medicines. The collaboration marked EVANIUM’s first commercial market entry in Germany and validated OPTISOLV® as an industry‑ready technology for established B2B partners.

Scaling for the future

Founded by a multidisciplinary team with backgrounds in pharmaceutical science and entrepreneurship, EVANIUM has rapidly evolved from an R&D‑driven startup into a technology partner for established companies. Following the seed round, the company has grown to more than 12 team members. EVANIUM will exhibit for the first time with its own stand at Vitafoods Europe and Food Ingredients in the Startup Areas. In 2026 alone, EVANIUM has produced and delivered more than two tons of material, proving the industrial readiness.

About EVANIUM

EVANIUM is a Germany-based life-science company developing innovative ingredients based on their IP-protected drug delivery technology OPTISOLV®. The company focuses on improving key properties such as solubility, stability, and bioavailability of ingredients for applications in nutraceuticals, functional foods, nutricosmetics, and pharmaceuticals. Through its proprietary OPTISOLV® Technology platform, EVANIUM enables more effective absorption and performance of ingredients, helping partners create high-performance, clean-label products. Headquartered in Regensburg, EVANIUM collaborates with industry partners to unlock the full potential of ingredients.

Read More